Susquehanna International Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Buy |
74,581
+12,036
| +19% | +$380K | ﹤0.01% | 2098 |
|
|
2025
Q1 | $2.08M | Buy |
62,545
+44,216
| +241% | +$1.47M | ﹤0.01% | 2256 |
|
|
2024
Q4 | $631K | Buy |
+18,329
| New | +$631K | ﹤0.01% | 3711 |
|
|
2024
Q3 | – | Sell |
-26,306
| Closed | -$794K | – | 6017 |
|
|
2024
Q2 | $794K | Buy |
+26,306
| New | +$794K | ﹤0.01% | 2857 |
|
|
2024
Q1 | – | Sell |
-9,793
| Closed | -$316K | – | 5997 |
|
|
2023
Q4 | $316K | Sell |
9,793
-26,504
| -73% | -$856K | ﹤0.01% | 4462 |
|
|
2023
Q3 | $1.19M | Buy |
36,297
+1,652
| +5% | +$54.1K | ﹤0.01% | 2373 |
|
|
2023
Q2 | $1.22M | Buy |
34,645
+16,756
| +94% | +$590K | ﹤0.01% | 2468 |
|
|
2023
Q1 | $584K | Buy |
+17,889
| New | +$584K | ﹤0.01% | 3615 |
|
|
2022
Q4 | – | Sell |
-12,994
| Closed | -$576K | – | 6248 |
|
|
2022
Q3 | $576K | Buy |
12,994
+5,483
| +73% | +$243K | ﹤0.01% | 3336 |
|
|
2022
Q2 | $366K | Buy |
7,511
+2,421
| +48% | +$118K | ﹤0.01% | 3733 |
|
|
2022
Q1 | $248K | Sell |
5,090
-2,286
| -31% | -$111K | ﹤0.01% | 4573 |
|
|
2021
Q4 | $315K | Buy |
+7,376
| New | +$315K | ﹤0.01% | 4432 |
|
|
2021
Q2 | – | Sell |
-13,801
| Closed | -$456K | – | 5573 |
|
|
2021
Q1 | $456K | Buy |
+13,801
| New | +$456K | ﹤0.01% | 3945 |
|